AKI Therapeutics A/S — Credit Rating and Financial Key Figures

AKI Therapeutics A/S (CVR number: 37509736K) is a company from HØRSHOLM. The company recorded a gross profit of 0 kDKK in 2023. The operating profit was -2022.3 kDKK, while net earnings were -1708.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was -74.4 %, which can be considered poor and Return on Equity (ROE) was -106.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 37.5 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. AKI Therapeutics A/S's liquidity measured by quick ratio was 0.7 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.